title: Plasma lipoprotein profiles of normocholesterolemic and hypercholesterolemic homozygotes for apolipoprotein E2(Arg158-->Cys) compared.
abstract: We compared plasma lipoprotein profiles of 15 individuals with normocholesterolemic (plasma cholesterol 4.81 +/- 0.90 mmol/L) familial dysbetalipoproteinemia (NFD) and 15 patients with hypercholesterolemic (plasma cholesterol 10.61 +/- 2.32 mmol/L) familial dysbetalipoproteinemia (HFD), matched for age and sex. All subjects were homozygous for apoE2(Arg158-->Cys). Compared with 15 normolipidemic controls (plasma cholesterol 5.47 +/- 0.92 mmol/L), subjects with NFD and HFD had greater cholesterol concentrations of large very-low-density lipoprotein (VLDL1), small VLDL (VLDL2), and intermediate-density lipoprotein, each of which was correlated to their plasma total cholesterol concentration. VLDL1 and VLDL2 subfractions were enriched in cholesteryl ester, and plasma cholesteryl ester transfer protein activities were increased in both NFD and HFD; however, absolute changes were larger in HFD than in NFD. Concentrations of low-density lipoprotein cholesterol were lower in HFD (1.89 +/- 0.48 mmol/L) and NFD (1.56 +/- 0.36 mmol/L) than in normolipidemic controls (3.35 +/- 0.73 mmol/L). We conclude that all subjects homozygous for apoE2(Arg158-->Cys) show features of dysbetalipoproteinemia.
authors.affiliation: Department of Cardiology, Medical Faculty, University of Leiden, The Netherlands.
authors.forename: S P
authors.initials: SP
authors.lastname: Zhao
authors.forename: A H
authors.initials: AH
authors.lastname: Smelt
authors.forename: A M
authors.initials: AM
authors.lastname: Van den Maagdenberg
authors.forename: A
authors.initials: A
authors.lastname: Van Tol
authors.forename: T F
authors.initials: TF
authors.lastname: Vroom
authors.forename: J A
authors.initials: JA
authors.lastname: Gevers Leuven
authors.forename: A
authors.initials: A
authors.lastname: Van der Laarse
authors.forename: F M
authors.initials: FM
authors.lastname: Van 't Hooft
mesh_terms: D000328:Adult; D053329:Apolipoprotein E2; D001057:Apolipoproteins E / Q000235:genetics*; D002352:Carrier Proteins / Q000097:blood; D002784:Cholesterol / Q000097:blood; D053480:Cholesterol Ester Transfer Proteins; D005260:Female; D006023:Glycoproteins; D006720:Homozygote; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood*; D006952:Hyperlipoproteinemia Type III / Q000097:blood*; D008074:Lipoproteins / Q000097:blood*; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010641:Phenotype; D002785:Sterol O-Acyltransferase / Q000097:blood; D014280:Triglycerides / Q000097:blood
chemical_list: D053329:Apolipoprotein E2; D001057:Apolipoproteins E; C506642:CETP protein, human; D002352:Carrier Proteins; D053480:Cholesterol Ester Transfer Proteins; D006023:Glycoproteins; D008074:Lipoproteins; D008079:Lipoproteins, VLDL; D014280:Triglycerides; D002784:Cholesterol; D002785:Sterol O-Acyltransferase